AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MONTELUKAST 4.000 Mg ;

12 registrations across 1 African market— 12 active

Markets with MONTELUKAST 4.000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
CLEAR AIR
Oral granules in sachet
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Montelair 4mg
Oral Granules
🇪🇬Egyptjedco international pharmaceuticalsactive
Opikast
Chewable Tablets
🇪🇬EgyptEl OBOUR MODERN PHARMACEUTICAL INDUSTRIES-EGYPTactive
Montelosab
Oral granules in sachet
🇪🇬Egyptvercureactive
Statukast 4 mg
Oral Granules
🇪🇬EgyptAdwiaactive
Lelipel 4 mg
Oral granules in sachet
🇪🇬EgyptGlobe International Pharmaceuticalsactive
CLEAR AIR
Oral granules in sachet
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Opikast
Chewable Tablets
🇪🇬EgyptEl OBOUR MODERN PHARMACEUTICAL INDUSTRIES-EGYPTactive
Montelair 4mg
Oral Granules
🇪🇬Egyptjedco international pharmaceuticalsactive
Statukast 4 mg
Oral Granules
🇪🇬EgyptAdwiaactive
Lelipel 4 mg
Oral granules in sachet
🇪🇬EgyptGlobe International Pharmaceuticalsactive
Montelosab
Oral granules in sachet
🇪🇬Egyptvercureactive

MONTELUKAST 4.000 Mg ; in Africa — Regulatory Overview

MONTELUKAST 4.000 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.